Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma.
Dillman
Robert O
RO
Clinical and Laboratory Cancer Research, Hoag Hospital, Hoag Cancer Center, Newport Beach, CA 92658, USA. rdillman@hoaghospital.org
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D016499:Radioimmunotherapy / Q000009:adverse effects; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; C422802:ibritumomab tiuxetan; C119496:tositumomab I-131